Gonadotrophin-releasing hormone agonists induce osteoporosis

Br J Rheumatol. 1994 Dec;33(12):1199-200. doi: 10.1093/rheumatology/33.12.1199.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Gonadotropin-Releasing Hormone / adverse effects
  • Gonadotropin-Releasing Hormone / agonists*
  • Gonadotropin-Releasing Hormone / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Osteoporosis / chemically induced*
  • Prostatic Neoplasms / drug therapy
  • Triptorelin Pamoate / adverse effects*
  • Triptorelin Pamoate / therapeutic use

Substances

  • Triptorelin Pamoate
  • Gonadotropin-Releasing Hormone